Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People With Type 2 Diabetes
Diabetes Technology and Therapeutics - United States
doi 10.1089/dia.2015.0290
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2016
Authors
Publisher
Mary Ann Liebert Inc